Funding Opportunities

Supports basic biomedical research with a current focus om understanding how humans and other organisms age and defining the biological mechanisms that prevent age-related diseases and disabilities.

The Foundation aims to stimulate new, creative research approaches that might not be funded by traditional sources or that might have been neglected by existing research programs.

A Senior Scholar Award designed to support established investigators working in US institutions awards up to $150,000 in direct costs over a four-year period to conduct research in the basic biological sciences relevant to understanding lifespan development processes and age-related diseases and disabilities.

Dedicated to advancing the mission of the National Institutes of Health (NIH) bu supporting and facilitating global health research conducted by US and international investigators, building partnerships between health research institutions in the US and abroad, and training the next generation of scientists to address global health needs.

Current funding opportunities include:

• Brain Disorders in the Developing World: Research Across the Lifespan - Deadline for application: February 14
• International Research Development Award - Provides support and protected time (three to five years) to advanced post-doctoral (at least two years beyond conferral of doctoral degree) US research scientists for an intensive, mentored research career development experience in a low- or middle-income country as defined by the World Bank leading to an independent research career focused on global health. FIC invites applications from biomedical, epidemiological, clinical, biostatistical, social, and behavioral scientists in the formative stages of their research careers. Deadline for application: March 4
• Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Training Award - Deadline for application: April 17

Through an aggressively funded research agenda, the Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease and ensuring the development of improved therapies for those living with Parkinson's today.

The Foundation works tirelessly to accelerate promising research toward clinical testing and breakthroughs for Parkinson's patients. While strong emphasis is on funding translational and clinical research, they also support high-risk/high-reward discovery work to help keep new ideas flowing into the drug development pipeline.

Founded by the Society of Gynecological Oncology in 1991, the Foundation for Women's Cancer funds research and training, as well as enduring education and public awareness of gynecologic cancer prevention, early detection, and optimal treatment.

Foundation programs are designed to raise public awareness of ways to prevent, detect, and treat gynecologic cancers, provide education about gynecologic cancers and the importance of seeking care first from a gynecologic oncologist if cancer is suspected or diagnosed, support promising, innovative gynecologic cancer research, and train clinicians/scientists to participate in clinically relevant research in collaboration with the National Cancer Institute.

Research and Training opportunities include: Stimulus/Seed Grants, Project Grants, Paired Grants (Junior and Senior Investigators), Mentor Grants Career Development Awards, Community Practice Clinical Trials Participation Awards, Innovative Research Awards, and the Ovarian Cancer Research Funding Sourcebook, which is a directory of foundations and agencies that support ovarian cancer and enable researchers to identify new grant opportunities.

For more than 60 years, the Council for International Exchange of Scholars has helped administer the Fulbright Scholar Program, the US Government's flagship academic exchange effort, designed to "increase mutual understanding between the people of the US and the people of other countries."

The Fulbright Program awards approximately 8,000 grants annually including: The Fulbright US Scholar Program, Fulbright Specialist Program, Fulbright Visiting Scholar Program, and Fulbright Scholar-In-Residence Program.

Founded in 1988, EGPAF is a nonprofit organization dedicated to preventing pediatric HIV infection and eliminating pediatric AIDS through research, advocacy, prevention, care, and treatment programs working in 15 countries around the world.

EGPAF continues to bring together leading international scientists to conduct basic, clinical, and operations research as part of their global efforts to eliminate pediatric AIDS.

Grant programs conducted over the past 20 years include:

• Elizabeth Glaser Scientist Awards - Five-year grant given to scientists and clinicians in the field of HIV/AIDS research. Notable research activities supported by this award include:
• Identifying candidates for an effective and safe pediatric HIV vaccine
• Understanding the immune response in children living with HIV
• Understanding the dynamics of HIV transmission during the breastfeeding period
• International Leadership Awards - Three-year grant focused on international investigations in PMTCT and HIV care and treatment. Recent awards were given for:
• Improving the effectiveness of PMTCT services
• Strengthening maternal and infant diagnosis of HIV
• Examining the impact of antiretroviral drugs on children

A private operating foundation created in 1988 to establish a new philanthropic business model to accelerate the way cures are discovered, Goldman Philanthropic Partnerships has created innovative research funding between donors, researchers, and medical institutions. They also seek out, validate, and co-fund innovative research that accelerates the search for cures for a range of catastrophic diseases.

Groundbreaking research is explored in all disciplines of medicine and most interested in intermediate-length studies (12-36 months. The Partnerships are willing to fund projects of any cost, and tend to fund young, talented researchers in all disciplines with ground-breaking ideas, although seasoned researchers looking to expand into new areas are also funded.

The Partnerships looks to fund research that will lead to a cure, regardless of the disease, but there is a strong interest in multiple myeloma and other hematological diseases. They also look for research that can translate from one disease to another and maintains a strong interest in children and young adults, although research is funded in any patient population where they believe there is a high likelihood of return on disease prevention, treatment, or cure.

An all-encompassing site with a plethora of available funds, managed by the US Department of Health and Human Services.